Bactroban Nasal, Nasensalbe

7680523610288 CH-52361 Nasensalbe
Bactroban Nasal, Nasensalbe
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
3
Selling units
3
Measure
g
Galenic form
Nasensalbe
Galenic group
Nasenmittel

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/06/2025
Patient information leaflet
Français
26/06/2025
Patient information leaflet
Italien
26/06/2025
Summary of Product Characteristics
Allemand
26/06/2025
Summary of Product Characteristics
Français
26/06/2025
Summary of Product Characteristics
Italien
26/06/2025

Detailed composition

Substance Quantity Type Category
mupirocinum
20.0 MG Substance Wirkstoff (Principe actif)
mupirocinum calcicum
- Substance WIZUS
vaselinum album
- Substance HNIDK
glyceroli mono/di/triadipas/alcanoas(C8,C10)/isostearas
- Substance HNIDK

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
52361
Drug name
Bactroban Nasal, Nasensalbe
Galenic form
NASA
ATC Code
R01AX06
Authorization status
Z
Dispensing category
A
First authorization
28/01/1994
Authorization expiration date
31/12/9999
IT Number
12.02.51
Domain
Human medicine
Field of application
Eliminierung von intranasalen Staphylokokken bei Trägern

Package details

Description (FR)
BACTROBAN Nasal ong nasal tb 3 g
Description (DE)
BACTROBAN Nasal Nasensalbe Tb 3 g
Market launch
28/01/1994
Narcotic (BTM)
No
Buy us a coffee Explore the data